References
- Lee YS, Jeong JM, Kim HW, Chang YS, Kim YJ, Hong MK, Rai GB, Chi DY, Kang WJ, Kang JH, Lee DS, Chung JK, Lee MC, Suh YG. An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK). Nucl. Med. Biol. 2006;33:677-683. https://doi.org/10.1016/j.nucmedbio.2006.04.004
- Chena X, Parka R, Shahiniana AH, Tohmea M, Khankaldyyanb V, Bozorgzadeha MH, Badinga JR, Moatsb R, Laugb WE, Contia PS. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl. Med. Biol. 2004;31:179-189. https://doi.org/10.1016/j.nucmedbio.2003.10.002
- Anderson CJ, Ferdani R. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biother.Radiopharm. 2009;24:379-393. https://doi.org/10.1089/cbr.2009.0674
- Gaertner FC, Kessler H, Wester HJ, Schwaiger M, Beer AJ. Radiolabelled RGD peptides for imaging and therapy. Eur. J. Nucl. Med. Mol. Imaging 2012;39:126-138. https://doi.org/10.1007/s00259-011-2028-1
-
Decristoforo C, Hernandez Gonzalez I, Carlsen J, Rupprich M, Huisman M, Virgolini I, Wester HJ, Haubner R. 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of
${\alpha}v{\beta}3$ integrin expression. Eur. J. Nucl. Med. Mol. Imaging 2008;35:1507-1515. https://doi.org/10.1007/s00259-008-0757-6 - Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ, Lee DS, Chung JK, Lee MC. Preparation of a Promising Angiogenesis PET Imaging Agent: 68Ga-Labeled c(RGDyK)-Isothiocyanatobenzyl-1,4,7-Triazacyclononane-1,4,7-Triacetic Acid and Feasibility Studies in Mice. J. Nucl. Med 2008;49:830-836. https://doi.org/10.2967/jnumed.107.047423
- Haubner R., Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J. Nucl. Med 2001;42:326-336.
-
Haubner R., Kuhnast B, Mang C, Weber WA, Kessler H, Wester H-J, Schwaiger M. [
$^{18}F$ ]Galacto-RGD: Synthesis, Radiolabeling, Metabolic Stability, and Radiation Dose Estimates. Bioconjugate Chem. 2004;15:61-69. https://doi.org/10.1021/bc034170n -
Chen X, Liu S, Hou Y, Tohme M, Park R, Bading JR, Conti P. MicroPET imaging of breast cancer
${\alpha}v$ -integrin expression with 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol 2004;6:350-359 https://doi.org/10.1016/j.mibio.2004.06.004 -
Li ZB, Cai W, Cao Q, Chen K, Wu Z, He L, Chen X. 64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor
${\alpha}v{\beta}3$ integrin expression. J Nucl Med 2007;48:1162-1171. https://doi.org/10.2967/jnumed.107.039859 - Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Release 2000;65: 271-284. https://doi.org/10.1016/S0168-3659(99)00248-5
- Jung KH, Kim HK, Park JA, Nam KS, Lee GH, Chang Y, Kim TJ. Gd Complexes of DO3A-(Biphenyl-2,2′-bisamides) Conjugates as MRI Blood-Pool Contrast Agents. ACS Med. Chem. Lett. 2013; 312:1003-1007.